Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Beckman Coulter, Inc.
Nucleic acid sample preparation platform for molecular diagnostic labs launched
November 4th, 2005
Beckman Coulter, Inc., (BEC) has begun shipping its new Vidiera NsP Nucleic Sample Preparation platform, a new solution for nucleic acid isolation, quantification, normalization and reaction set-up for downstream assay analysis. Vidiera NsP is based on Beckman Coulter's proven Biomek automation and diagnostic primary tube handling technologies and is specifically designed to meet the growing need for molecular testing in hospital and reference laboratories. Vidiera NsP is ideal for molecular diagnostic applications in virology and pathology and can be integrated with Beckman Coulter's recently announced Vidiera NsD Nucleic Sample Detection System....
Source: Biotech Law Weekly (2005-11-04)
|
